Allergan reaction: Teva meets banks for jumbo $34bn M&A financing

Dan Alderson,

Elly Whittaker

October 22, 2015 06:45 PM

Teva, the New York-listed Israeli pharmaceutical company, held a meeting with banks on Wednesday for the syndication of $33.75bn of loans to buy generic drug business Allergan Generics.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated Loans Credit Suisse Bank of America UK Citi Barclays Sumitomo Mitsui Financial Group Mizuho Morgan Stanley BNP Paribas News content Israel Emerging Market Loans United States Investment Grade Loans Emerging Markets HSBC Middle East Loans EM Middle East

DA

Dan Alderson

EW

Elly Whittaker